Stock Analysis

Have Insiders Sold Imaflex Inc. (CVE:IFX) Shares Recently?

TSXV:IFX
Source: Shutterstock

Investors may wish to note that an insider of Imaflex Inc., Gerald Phelps, recently netted CA$108k from selling stock, receiving an average price of CA$1.08. On the bright side, that's just a small sale and only reduced their holding by 2.5%.

See our latest analysis for Imaflex

Imaflex Insider Transactions Over The Last Year

Notably, that recent sale by Gerald Phelps is the biggest insider sale of Imaflex shares that we've seen in the last year. So we know that an insider sold shares at around the present share price of CA$1.00. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. We note that this sale took place at around the current price, so it isn't a major concern, though it's hardly a good sign.

The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

insider-trading-volume
TSXV:IFX Insider Trading Volume November 30th 2020

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Does Imaflex Boast High Insider Ownership?

Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. Imaflex insiders own about CA$26m worth of shares (which is 52% of the company). I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.

What Might The Insider Transactions At Imaflex Tell Us?

An insider sold Imaflex shares recently, but they didn't buy any. And even if we look at the last year, we didn't see any purchases. But it is good to see that Imaflex is growing earnings. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. To assist with this, we've discovered 3 warning signs that you should run your eye over to get a better picture of Imaflex.

Of course Imaflex may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

When trading Imaflex or any other investment, use the platform considered by many to be the Professional's Gateway to the Worlds Market, Interactive Brokers. You get the lowest-cost* trading on stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted


Valuation is complex, but we're helping make it simple.

Find out whether Imaflex is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020


Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.